Human Immunodeficiency Virus Postexposure Prophylaxis for Adolescents and Children

Abstract

ABSTRACT. Children and adolescents are at risk for human immunodeficiency virus (HIV) infection. Transmission occurs through perinatal exposures, injecting drug use, consensual and nonconsensual sex, needlestick and sharp injuries, and possibly some unusual contacts. Youth engaging in high-risk sexual activities are especially endangered. Half of the estimated worldwide 5.3 million new HIV infections occur in adolescents and young adults aged 15 to 24. Of 20 000 known new adult and adolescent cases in the United States, 25% involve 13-to 21-year-olds. More than 1.4 million children worldwide (aged 15 and younger) are believed to be infected, and >1640 new cases are diagnosed daily. Of the 432 000 people reported to be living with HIV or acquired immunodeficiency syndrome (AIDS) in the United States, 5575 are children under 13.HIV postexposure prophylaxis (PEP) is a form of secondary HIV prevention that may reduce the incidence of HIV infections. HIV PEP is commonly conceived of as 2 types: occupational and nonoccupational. Occupational HIV PEP is an accepted form of therapy for health care workers exposed to HIV through their jobs. A landmark study of healthcare workers concluded that occupational HIV PEP may be efficacious. Well-established US national guidelines for occupational HIV PEP exist for this at-risk population.Nonoccupational HIV PEP includes all other forms of HIV PEP, such as that given after sexual assault and consensual sex, injecting drug use, and needle-stick and sharp injuries in non-health care persons. Pediatric HIV PEP is typically the nonoccupational type. The efficacy of nonoccupational HIV PEP is unknown. The presumed efficacy is based on a collection of animal and human data concerning occupational, perinatal, and nonoccupational exposures to HIV. In contrast to occupational HIV PEP, there are no national US guidelines for nonoccupational HIV PEP, and few recommendations are available for its use for adolescents and children. Regardless of this absence, there is encouraging evidence supporting the value of HIV PEP in its various forms in pediatrics.Although unproven, the presumed mechanism for HIV PEP comes from animal and human work suggesting that shortly after an exposure to HIV, a window period exists during which the viral load is small enough to be controlled by the body's immune system. Antiretroviral medications given during this period may help to diminish or end viral replication, thereby reducing the viral inoculum to a more potentially manageable target for the host's defenses.HIV PEP is accepted practice in the perinatal setting and for health care workers with occupational injuries. The medical literature supports prescribing HIV PEP after community needle-stick and sharp injuries and after sexual assault from sources known or likely to be HIV-infected. HIV PEP after consensual unprotected intercourse between HIV sero-opposite partners has had growing use in the adult population, and can probably be utilized for children and adolescents. There is less documented experience...

Knowledge and Practice of Health Care Workers regarding Needle Stick Injuries in a Tertiary Care Center of Nepal

“…HIV post exposure prophylaxis is an established form of secondary HIV prevention that may reduce the incidence of HIV infections following exposure. 12,13 Although there is no direct evidence for its efficacy the combination multi drug therapy is believed for its success in treating HIV-infected individuals. All HCWs must be counselled that the drugs are not 100% effective in preventing HIV seroconversion.…”

Profile of rape victims attending the Karl Bremer Hospital Rape Centre, Tygerberg, Cape Town

“…9 Rape may increase the risk of HIV transmission compared with consensual sex because trauma is more likely 10,11 and STI prevalence is high in victims' 12 and assailants. 9,11,[13][14][15][16][17][18] These infections (syphilis, trichomoniasis, gonorrhoea, herpes, etc.) are found to increase susceptibility to HIV infection.…”

Venereal Diseases in Children

“…160mg/m 2 , 6 saatte bir + Lamivudine 4 mg/kg 2x1 şeklindeyken, 12 yaşından büyüklere ise, zidovudine 300 mg 2x1 + Lamivudine 150 mg 2x1 olarak uygulanır 36 . Ayrıca çinko desteğinin yetişkin ve çocuk hastalarda fırsatçı infeksiyonları azaltabileceği bazı çalışmalarda ifade edilmesine rağmen, tüm çalışmalar incelendiğinde, bu etkinin yetişkinlerde gösterildiği, fakat çocuklarda plasebodan daha etkili olmadığı bildirilmiştir 37 .…”